Dr. Dashkevich

MVT Aortic 2022, vol.2

– For a patient with endocarditis, should we consider a biological or mechanical prosthesis?

– Briefly see an interesting patient case, accompanied by detailed photos and explanations.

– Don’t forget to pay attention to the anterior mitral leaflet, and strongly consider your coronary reimplantation strategy.

Prof. Van Praet – MVT Intermediate 2021

Prof. Bonaros – MVT Intermediate 2021

Can Gollmann-Tepeköylü, Austria 

Keywords: aortic root replacement; aortic stenosis; aortic valve replacement; Bentall; Valsalva graft

Although the majority of Bentall procedures have been performed with mechanical valves, the use of bioprosthetic valves is increasing. Modifications to the Bentall procedure may further enable the use of bioprosthetic valves: use of Valsalva pseudosinuses may reduce stress on the bioprosthetic leaflets and reduce the incidence of thromboembolism.

Chirichilli et al. routinely perform the Bentall procedure using the Valsalva graft with a Carpentier‑Edwards PERIMOUNT or PERIMOUNT Magna Ease valve. Here, they present the long‑term follow-up data assessing durability and valve-related complications.

Click on the link below to find out more about the performance of the PERIMOUNT valves combined with a modified Bentall procedure.  

Click here to access the full publication 

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Magna, Magna Ease, PERI, PERIMOUNT and PERIMOUNT Magna are trademarks or service marks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners.

© 2020 Edwards Lifesciences Corporation. All rights reserved.

Edwards Lifesciences • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com

Keywords: aortic bioprostheses; aortic stenosis; aortic valve replacement

Surgical aortic valve replacement (SAVR) is still offered to elderly populations despite the potential for structural valve degeneration. Currently, however, there is limited comparative data on the long-term durability of different SAVR prostheses.

Reporting outcomes including repeat aortic valve replacement, prosthetic valve endocarditis and late all-cause mortality, Biancari et al. present key results from a retrospective, non-randomised, propensity-matched comparative analysis of the Trifecta and Carpentier-Edwards PERIMOUNT Magna Ease valves. The authors compared the outcomes of 2,216 patients who had undergone the procedure to implant one of the two SAVR prostheses.

Click the link below for an update on the latest research in aortic valve replacement.

Click here to access the full publication

For professional use. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).

Edwards devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.

Edwards, Edwards Lifesciences, the stylized E logo, Carpentier-Edwards, Magna, Magna Ease, PERI, PERIMOUNT and PERIMOUNT Magna are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks or service marks are the property of their respective owners.